Slate Run Pharmaceuticals recalls Cinacalcet Hydrochloride Tablets 60…
Slate Run Pharmaceuticals recalls Cinacalcet Hydrochloride Tablets 60 mg and 1 more
- Published
- 26 Mar 2025
- Units affected
- 2 products
- Agency
- FDA
- Country
- United States
The hazard
CGMP deviations: The presence of nitrosamine impurity above the acceptable daily intake limits.
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Cinacalcet Hydrochloride Tablets 60 mg, 30-count bottle, Rx only, Distr. by: Slate Run Pharma., LLC, Columbus, Ohio 43215, Mfg. by: Piramal Pharma Limited, Madhya Pradesh, India, NDC 70436-008-04
Cinacalcet Hydrochloride Tablets 30 mg, 30-count bottle, Rx only, Distr. by: Slate Run Pharma., LLC, Columbus, Ohio 43215, Mfg. by: Piramal Pharma Limited, Madhya Pradesh, India, NDC 70436-007-04
- Brand / company
- Slate Run Pharmaceuticals
- Codes / lots
- Lot # 109797, Exp 11/2026 | Lot # 07711, Exp 07/2025; 08900, Exp 09/2026; 08899, Exp 09/2026
- Distribution
- Product was distributed to 8 distributors who may have further distribute the product nationwide.
- Recall status
- Completed
Source: U.S. Food and Drug Administration, published 26 Mar 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.